Endomyocardial Biopsy is a procedure that removes tiny samples of heart muscle (myocardium) for microscopic analysis. It is a diagnostic test used in cardiology to identify specific causes of cardiomyopathy, myocarditis, and transplant rejection. It is most commonly performed via a catheter placed into the right side of the heart. It helps connect clinical findings to tissue-level pathology when noninvasive tests are inconclusive.

Cardiac Amyloidosis is a myocardial disease caused by abnormal protein deposits (amyloid) infiltrating the heart. It is a form of restrictive cardiomyopathy that can lead to heart failure, arrhythmias, and conduction disease. It is most often discussed in cardiology, internal medicine, hematology, and cardiac imaging. It is commonly evaluated with echocardiography, cardiac magnetic resonance (CMR), nuclear scintigraphy, and sometimes endomyocardial biopsy.

Cardiac Sarcoidosis is heart involvement by sarcoidosis, an inflammatory disease characterized by granulomas. It is a cardiac pathology that can affect the myocardium (heart muscle) and the cardiac conduction system. It is commonly discussed in cardiology, electrophysiology, and heart failure care because it can cause arrhythmias and cardiomyopathy. It is most often identified through clinical evaluation combined with cardiac imaging and rhythm assessment.

Cardiac Autonomic Neuropathy is dysfunction of the autonomic nerves that regulate heart rate, rhythm, and blood pressure. It is a pathophysiologic complication most often discussed in diabetes care and cardiovascular medicine. It can present with subtle abnormalities on electrocardiogram (ECG) and heart rate variability (HRV) testing before symptoms appear. It matters because it can change risk profiles for syncope, arrhythmia, ischemia, and perioperative instability.

Catecholaminergic Polymorphic VT is an inherited arrhythmia syndrome that causes abnormal fast heart rhythms from the ventricles during adrenergic stress. It is a cardiac electrophysiology disorder rather than a structural heart disease. It is most commonly discussed in syncope evaluation, exercise-related palpitations, and sudden cardiac death risk assessment. It is frequently encountered in pediatric and young adult cardiology, emergency care, and inherited arrhythmia clinics.

Brugada Syndrome is an inherited cardiac **channelopathy** associated with malignant ventricular arrhythmias. It is defined by a characteristic **electrocardiogram (ECG)** pattern, typically in the right precordial leads, and a risk of **ventricular fibrillation (VF)**. It belongs to the clinical domain of **cardiac electrophysiology** and sudden cardiac death prevention. It is commonly discussed in emergency care, syncope evaluation, and inherited arrhythmia clinics.

Inherited Cardiomyopathy is a group of heart muscle diseases caused by genetic variants that can run in families. It primarily affects the myocardium (heart muscle) and may change cardiac structure, function, or electrical stability. It is discussed in clinical cardiology, emergency care, and cardiovascular imaging because it can present with heart failure or arrhythmia. It is commonly identified during evaluation of symptoms, abnormal electrocardiogram (ECG), or family history of cardiomyopathy or sudden cardiac death.

Cardiac Genetics is the study of how inherited and acquired genetic variation influences heart structure and function. It sits at the intersection of cardiology, molecular biology, and clinical diagnostics. It is commonly used to evaluate inherited cardiomyopathies, arrhythmia syndromes, and familial aortopathies. It also informs family screening, risk stratification, and selected management decisions in cardiovascular care.

AI in Cardiology refers to the use of artificial intelligence (AI) methods to support cardiovascular care. It is applied across anatomy, physiology, disease diagnosis, risk assessment, and treatment planning. Common inputs include the electrocardiogram (ECG), echocardiography, cardiac magnetic resonance (CMR), cardiac computed tomography (CT), and the electronic health record (EHR). It is most often used as clinical decision support rather than as an independent decision-maker.

Digital Cardiology is the use of digital tools and data to support cardiovascular care. It spans diagnosis, monitoring, and long-term management of heart and vascular disease. It commonly includes wearable sensors, remote monitoring, telehealth, and software that analyzes cardiac data. It is used across outpatient clinics, emergency care pathways, hospital cardiology services, and cardiac rehabilitation programs.